目的 分析制药企业修改药品说明书时的理性行为,提出促进这些企业积极主动修改药品说明书的政策和建议。方法 利用博弈论方法,分析我国制药企业修改说明书时与市场(患者及其代理人—医生)、政府有关部门之间的博弈均衡。结果 基于成本考虑,企业不愿意主动修改药品说明书。结论 我国药品监管部门应完善相关法律法规,制定明确可操作的药品说明书修改程序,并降低企业主动修改药品说明书的成本,激励患者(也可以是医生)积极报告因未修改说明书导致的药物不良反应问题,同时加大对不主动修改药品说明书行为的惩罚力度,促使制药企业及时、主动修改说明书。
Abstract
OBJECTIVE To analyze the rational behaviors of pharmaceutical companies when modifying drug instructions, and puts forward policies and suggestions for promoting these enterprises to actively modify drug instructions. METHODS The game theory is used to analyze the game equilibrium between enterprises and the market (patients and their agents -doctors) or the relevant government departments when they modify the instructions of the pharmaceutical enterprises in China. RESULTS Based on cost considerations, enterprises are unwilling to modify drug instructions voluntarily. CONCLUSION The drug regulatory departments in China should improve the relevant laws and regulations, and formulate specific operational drug instructions to modify the program.These measures would reduce the cost of enterprises to take the initiative to modify the drug instructions, and encourage the patient (and also be a doctor) to actively report the problem of adverse drug reactions caused by the unmodified instructions and increase penalties for not actively modify the behavior of drug instructions.At last the pharmaceutical companies could timely and actively modify instructions.
关键词
修改药品说明书 /
成本 /
博弈 /
均衡 /
政府规制
{{custom_keyword}} /
Key words
modifying drug instructions /
cost /
game /
equilibrium /
government regulation
{{custom_keyword}} /
中图分类号:
R951
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ZHANG X, LIU Y M, ZHANG Q H, et al. Analysis on the status of safety items in drug instructions[J]. Guide Chin Med(中国医药指南),2011,9 (32):464-465.
[2] YAN J. Pay attention to the warning language in the Chinese patent medicine instruction[J]. J Chin Pharm(中国药房), 2012,23(15):1435-1436.
[3] LIN R H, WEI Y H, HE J M. Investigation and analysis of the adverse reactions, taboos and notices in 129 Chinese patent medicines[J]. Qindao Med J(青岛医药卫生), 2012,44(4):287-289.
[4] XIAO H L. Analysis of 71 precautions in samples of drug instructions[J]. Drug Eval Res(药物评价研究),2014,37(2):97-102.
[5] GAO Y Y, CHEN Y. Problems and related analysis of adverse drug reactions in prescription drug instructions[J]. Chin J Mod Drug App(中国现代药物应用), 2013,7(12):27-28.
[6] XIA D S. Analysis and risk control suggestions on drug labeling in Chinese drug instructions[J]. Chin J Hosp Pharm(中国医院药学杂志), 2014,34(22):1946-1951.
[7] ZHANG Y T, TANG J, YANG J H, et al. Study on labeling of elderly drugs in drug instructions in China[J]. Chin J Drug Eval(中国药物评价), 2016,33(5):440-442.
[8] XIA D S. Analysis and risk control suggestions on drug labeling of pregnant women and lactating women in Chinese drug instructions[J]. Chin J Pharmacov(中国药物警戒), 2015,12(4):211-218.
[9] LI G R. Investigation and analysis of the implementation of revision notice for CFDA drug instructions in a certain area[J]. Chin J Ratin Drug Use(中国合理用药探索),2017,14(2):60-62.
[10] LI X L, FENG X. Investigation and analysis of 490 drug instructions information on safe medication during pregnancy[J]. Chin Pharm J(中国药学杂志),2013,48(21):1886-1888.
[11] ZHANG L, TAN L, WANG S H. Investigation and analysis of the off-label drug use in 24 medical institutions in China[J]. Chin Pharm J(中国药学杂志),2016, 51(2):151-154.
[12] FU S Y, YANG Y. Analysis and policy recommendations of China's hierarchical diagnosis and treatment system based on game theory[J]. Chin Hosp Mange(中国医院管理),2018, 38(2):24-25.
[13] LI M S, REN Y, YANG Y. Research on drug instruction management in the United States[J]. Chin J Pharmacov(中国药物警戒),2014,11(12):741.
[14] LUO S X. Pfizer Won a $2 Billion 300 Million Fine in Illegal Marketing [N]. Chin Med Newspaper(中国医药报),2009,9(17):B07 Edition.
[15] HUA B. Bayer, it's a big trouble[J]. Med World(医药世界),2001(10):18-21.
[16] FDA. Federal Food, Drug, and Cosmetic Act (FD&C Act). SUBCHAPTER II-DEFINITIONS§321. Definitions; generally. [S/OL]. (1938-01-25) [2014-05-27]. http://www.gpo.gov/fdsys/pkg/USCODE-2010-title 21/html/USCODE-2010-title 21-chapq-subchap Ⅱ.htm.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
广东省药品说明书风险管理方法的研究课题项目资助;辽宁省教育厅人文社会科学研究项目资助(201610163W05);沈阳药科大学工商管理学院中青年教师事业发展支持计划资助
{{custom_fund}}